A Study of Plasma miR-23a Expression in Vitiligo Patients

IMMUNOHISTOCHEMICAL EXPRESSION OF MELAN A AND ITS RELATION TO EXPRESSION OF CXCR3 IN VITILIGO LESIONS

Expression of Tyrosinase, Tyrp1 and Tyrp2 in vitiligo

Interleukin-36α Expression in Vitiligo Skin Lesions and Its Association with Disease Pattern, Activity, and Severity

Histopathological Changes in Lesional and Perilesional Vitiligo Skin

Assessment of C-X-C Motif Chemokine Ligand 10 (CXCL10) Serum Level in Patients with Vitiligo

Evaluation of the Role of Apoptosis in Vitiligo: Immunohistochemical Expression of P53, Bcl-2 and MART-1 Antigens

Estimation of Serum Granulysin in Vitiligo patients

Assessment of Micro Ribonucleic Acid 320 Expression Level in Plasma of ‎Vitiligo Patients Attending Suez Canal University Hospitals

Cutaneous Forkhead Box P3 (FOXP3) Immune-Expression in Vitiligo Patients